Incidence and clinical significance of anti-PF4/heparin antibodies of the IgG, IgM, and IgA class in 755 consecutive patient samples referred for diagnostic testing for heparin-induced thrombocytopenia.
about
Prospective evaluation of the '4Ts' score and particle gel immunoassay specific to heparin/PF4 for the diagnosis of heparin-induced thrombocytopenia.Heparin-induced thrombocytopenia: a prospective study on the incidence, platelet-activating capacity and clinical significance of antiplatelet factor 4/heparin antibodies of the IgG, IgM, and IgA classes.Serologic results in >1000 patients with suspected heparin-induced thrombocytopenia.Heparin-induced thrombocytopenia in patients requiring prolonged intensive care unit treatment after cardiopulmonary bypass.Immune mechanisms in heparin-induced thrombocytopenia: no evidence for immunoglobulin M anti-idiotype antibodies.Lepirudin in the management of patients with heparin-induced thrombocytopenia.IgG-class anti-PF4/heparin antibodies and symptomatic DVT in orthopedic surgery patients receiving different anti-thromboembolic prophylaxis therapeutics.Heparin-induced thrombocytopenia: present and future.Incidence of isolated heparin-induced thrombocytopenia and risk of thrombosis by IgG-specific anti-PF4/heparin ELISA.Usefulness of anti-PF4/heparin antibody test for intensive care unit patients with thrombocytopenia.Dynamic antibody-binding properties in the pathogenesis of HIT.Improving the specificity of the PF4 ELISA in diagnosing heparin-induced thrombocytopenia.Heparin-induced thrombocytopenia: the role of platelets genetic polymorphisms.Predictive value of the 4Ts scoring system for heparin-induced thrombocytopenia: a systematic review and meta-analysis.Novel diagnostic assays for heparin-induced thrombocytopeniaFcγRIIa proteolysis as a diagnostic biomarker for heparin-induced thrombocytopenia.Complex formation with nucleic acids and aptamers alters the antigenic properties of platelet factor 4.Anti-platelet factor 4/heparin antibodies in patients with impaired graft function after liver transplantation.Prevalence and clinical implications of anti-PF4/heparin antibodies in intensive care patients: a prospective observational study.Argatroban versus Lepirudin in critically ill patients (ALicia): a randomized controlled trialA genome-wide association study of heparin-induced thrombocytopenia using an electronic medical record.Anti-platelet factor 4/polyanion antibodies mediate a new mechanism of autoimmunity.Effect of pH and ionic strength on the binding strength of anti-PF4/polyanion antibodies.
P2860
Q33374563-3CAF154A-6D25-4794-97B0-FC54204474FAQ33375177-19854023-FFA2-434D-8E9D-89E8059C8B5DQ33376811-4B20F764-6288-4A38-8EC1-7F4AE8D23454Q33377839-965D91BB-9810-4DE1-830D-7CE7DFA35114Q33384840-6B525B6D-CCC3-44F6-86DA-437166145E7DQ33385972-7BA7A2CB-702F-405A-9EE7-27D1F0DBEE2DQ33393788-2DAC02BA-D5E9-43C3-A1C3-336159CB8E5FQ33394188-3A5564A1-05DD-461F-A59E-E7F7D2E006EAQ33398047-CBFAB369-7876-4821-BEBA-E66930BB87A1Q33400605-05C4014E-8DB8-4794-8490-178DFA2C88C7Q33401163-5B59F31C-8357-420F-B3B9-46A1EDFF902BQ33401466-DBA14FFC-3D24-422F-A551-F44DE7375D75Q33402336-85AF3287-E997-4CAD-8409-9BE1C3917C2CQ33403395-1BEC1F47-00C5-40CB-BD53-5D81C02D89ABQ33406133-BF568086-5FD7-427E-8291-337DEFF18256Q33406804-BD9CDEA5-C2ED-4250-9469-81FD2D60A3D1Q33407740-87FB4AB6-5D03-40FC-8B7E-A7841BADB3F3Q33414125-1C7315A2-312F-4DF0-8DAC-7B80AE3BA169Q33416315-E0C84944-E561-4C24-A745-9AAC4CDB26AAQ33418376-51881723-214F-4C6B-A042-32F167700DB8Q33419319-CEA0015B-7216-4A59-9975-9C8B7C77DF9AQ33442026-F76BF2E1-F5C6-4B6F-AFEC-2ADE01FE19B7Q33443669-01F06EB4-10E0-4F7F-A4D1-5360A56CAC7B
P2860
Incidence and clinical significance of anti-PF4/heparin antibodies of the IgG, IgM, and IgA class in 755 consecutive patient samples referred for diagnostic testing for heparin-induced thrombocytopenia.
description
2006 nî lūn-bûn
@nan
2006 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Incidence and clinical signifi ...... arin-induced thrombocytopenia.
@ast
Incidence and clinical signifi ...... arin-induced thrombocytopenia.
@en
type
label
Incidence and clinical signifi ...... arin-induced thrombocytopenia.
@ast
Incidence and clinical signifi ...... arin-induced thrombocytopenia.
@en
prefLabel
Incidence and clinical signifi ...... arin-induced thrombocytopenia.
@ast
Incidence and clinical signifi ...... arin-induced thrombocytopenia.
@en
P2093
P2860
P1476
Incidence and clinical signifi ...... arin-induced thrombocytopenia.
@en
P2093
Antje Wessel
David Juhl
Norbert Lubenow
Petra Eichler
Ulrike Strobel
P2860
P304
P356
10.1111/J.1600-0609.2005.00621.X
P577
2006-02-06T00:00:00Z